万方数据
万方数据
再论特发性肺纤维化的药物治疗
作者:徐作军
作者单位:100730,中国医学科学院北京协和医院呼吸内科
刊名:
中华结核和呼吸杂志
英文刊名:Chinese Journal of Tuberculosis and Respiratory Diseases
年,卷(期):2014,37(9)
参考文献(10条)
1.Rahgu G;Collard HR;Egan J J An Official ATS/ERS/ JRS/ALAT Statement:idiopathic pulmonary fibrosis:evidence-based guidelines for diagnosis and management 2011
2.American Thoracic Society (ATS);the European Respiratory Society (ERS)Idiopathic pulmonary fibrosis:diagnosis and treatment.International consensus statement 2000
3.American Thoracic Society (ATS);The European Respiratory Society (ERS)American Thoracic Society/European Respiratory Society international multidisciplinary consensus classification of the idiopathic interstitial pneumonias 2002
4.Raghu G;Anstrom K J;King TE Jr Prednisone,azathioprine,and N-acetylcysteine for pulmonary fibrosis 2012
5.Martinez FJ;Andrade JA de;Anstrom KJ Randomized trial of acetylcysteine in idiopathic pulmonary fibrosis 2014
6.Noth I;Anstrom KJ;Calvert SB A placebo-controlled randomized trial of warfarin in idiopathic pulmonary fibrosis 2012
7.Taniguchi H;Ebina M;Kondoh Y Pirfenidone clinical study group in Japan.Pirfenidone in idiopathic pulmonary fibrosis 2010(04)
8.Noble PW;Albera C;Bradford WZ Pirfenidone in patients with idiopathic pulmonary fibrosis (CAPACITY):two randomized trials 2011
9.King TE;Bradford WZ;Castro-Bernardini S A phase 3 trial of pirfenidone in patients with idiopathic pulmonary fibrosis 2014
10.Richeldi L;du Bois RM;Raghu G Efficacy and safety of nintedanib in idiopathic pulmonary fibrosis 2014
引用本文格式:徐作军再论特发性肺纤维化的药物治疗[期刊论文]-中华结核和呼吸杂志 2014(9)